274 results on '"Fanaroff, Alexander C."'
Search Results
2. Racial Differences in Presentation and Outcomes After Peripheral Arterial Interventions: Insights From the NCDR-PVI Registry
3. Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention
4. Management of Persistent Angina After Myocardial Infarction Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study.
5. Association Between Diagnosis-to-Limb Revascularization Time and Clinical Outcomes in Outpatients With Chronic Limb-Threatening Ischemia: Insights From the CLIPPER Cohort.
6. Risk Prediction in Percutaneous Coronary Intervention: Solving the Last Mile Problem
7. Economic Considerations in Access to Transcatheter Aortic Valve Replacement
8. Intensive Care Utilization in Stable Patients With ST-Segment Elevation Myocardial Infarction Treated With Rapid Reperfusion
9. High-Sensitivity Troponin in Patients With Cancer
10. Lack of Association Between Percutaneous Coronary Intervention and Transcatheter Aortic Valve Replacement Outcomes in New York Hospitals
11. Antithrombotic Regimens in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement: Trials Evaluating Patient-Centered Outcomes Needed
12. OR6-5 | Variation in Likelihood of Undergoing Percutaneous Coronary Intervention for ST Segment Elevation Myocardial Infarction among United States Hospitals
13. Association Between Cardiac Catheterization Laboratory Pre-Activation and Reperfusion Timing Metrics and Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Report From the ACTION Registry
14. Patient and Staff Perceptions of Universal Severe Acute Respiratory Syndrome Coronavirus 2 Screening Prior to Cardiac Catheterization and Electrophysiology Laboratory Procedures
15. Abstract 13567: Variability in Reported Post-percutaneous Coronary Intervention Mortality Among Physicians Practicing at Multiple Sites in New York State
16. Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated events
17. Association Between 90-Minute Door-to-Balloon Time, Selective Exclusion of Myocardial Infarction Cases, and Access Site Choice: Insights From the Cardiac Care Outcomes Assessment Program (COAP) in Washington State
18. Copayment Reduction Voucher Utilization and Associations With Medication Persistence and Clinical Outcomes: Findings From the ARTEMIS Trial
19. Racial, Ethnic, and Socioeconomic Inequities in Access to Left Atrial Appendage Occlusion
20. Physiologic Assessment of Stent Deployment: SEARCHing for Answers With Post-Percutaneous Coronary Intervention Fractional Flow Reserve
21. Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials
22. Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention: Report From the NCDR CathPCI Registry
23. Days Alive and Out of Hospital: Exploring a Patient-Centered, Pragmatic Outcome in a Clinical Trial of Patients With Acute Coronary Syndromes
24. Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week
25. A Path Forward for Regenerative Medicine: Navigating Regulatory Challenges: Summary of Findings From the Cardiac Safety Research Consortium/Texas Heart Institute International Symposium on Cardiovascular Regenerative Medicine
26. Focusing on the Future of Cardiovascular Outcomes Research: Highlights From the American Heart Association/American Stroke Association Quality of Care and Outcomes Research 2018 Scientific Sessions
27. Abstract 16543: The Atherosclerosis Candidate Gene Product Kalirin Reduces Atherosclerosis via Macrophage-Specific Mechanisms
28. Abstract 15864: ICU Utilization in Stable ST-segment Elevation Myocardial Infarction Patients Treated With Rapid Reperfusion: A Report From ACTION Registry
29. Abstract 14533: Association Between Operator PCI Volume and Long-term Outcomes in Older Adults: A Report From The NCDR CathPCI Registry
30. Independence of clinical events committees : A consensus statement from clinical research organizations
31. Peripheral Artery Disease and Transcatheter Aortic Valve Replacement Outcomes: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Therapy Registry
32. Percutaneous Coronary Intervention in Acute Coronary Syndrome and Cardiogenic Shock
33. EPIDEMIOLOGY AND OUTCOMES OF PATIENTS READMITTED TO THE INTENSIVE CARE UNIT AFTER CARDIAC INTENSIVE CARE UNIT ADMISSION
34. Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease
35. Identifying racial, ethnic and socioeconomic inequities in the use of novel P2Y12 inhibitors after percutaneous coronary intervention
36. Managing Myocardial Infarction in the Age of Multimorbidity.
37. Rural-Urban Disparities in Cardiovascular Outcomes
38. Hospital-Level Percutaneous Coronary Intervention Performance With Simulated Risk Avoidance
39. Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US
40. Atrial Fibrillation and Coronary Artery Disease: A Long-Term Perspective on the Need for Combined Antithrombotic Therapy
41. Socioeconomic and Geographic Characteristics of Hospitals Establishing Transcatheter Aortic Valve Replacement Programs, 2012–2018
42. 1 Month of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention
43. Comparison of Patients Undergoing Percutaneous Coronary Intervention in Contemporary U.S. Practice With ISCHEMIA Trial Population
44. Geographic and Socioeconomic Disparities in Major Lower Extremity Amputation Rates in Metropolitan Areas
45. Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week.
46. EFFECT OF APIXABAN VERSUS VITAMIN K ANTAGONIST AND ASPIRIN VERSUS PLACEBO ON DAYS ALIVE AND OUT OF HOSPITAL IN THE AUGUSTUS RANDOMIZED CONTROLLED TRIAL
47. Adding Precision to Defining Bleeding and Ischemic Risk With PCI in Cancer Patients
48. Association of Health Insurance Payer Type and Outcomes After Durable Left Ventricular Assist Device Implantation: An Analysis of the STS-INTERMACS Registry
49. Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US
50. Electronic Health Record Integration of Predictive Analytics to Select High-Risk Stable Patients With Non–ST-Segment–Elevation Myocardial Infarction for Intensive Care Unit Admission
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.